HHUSF (HHUSF) Stock Price & Analysis
HHUSF (HHUSF) fell 11.54% to USD 17.25 as of June 9, 2026 at 23:53 UTC, according to Nexqual real-time market data.
HHUSF last closed at USD 19.5; the session ranged USD 17.25–18 on volume of 1,000 shares. Market capitalization is $33.45B, with a 52-week range of USD 3.62–22.59 (PNK). Source: Nexqual, June 9, 2026 at 23:53 UTC.
Key Statistics (as of June 9, 2026 at 23:53 UTC)
| Price | USD 17.25 |
|---|---|
| Change | ▼ 11.54% (down) |
| Previous Close | USD 19.5 |
| Open | USD 18 |
| Day Range | USD 17.25 – 18 |
| 52-Week Range | USD 3.62 – 22.59 |
| Volume | 1,000 shares |
| Market Cap | $33.45B |
| Exchange | PNK |
Technical Analysis (HHUSF)
Nexqual's technical model rates HHUSF "NEUTRAL" based on 3 bullish and 2 bearish signals across 124 daily candles, as of June 9, 2026 at 23:53 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 52.62 (neutral) |
| vs SMA50 | Above (USD 15.06) |
| MACD | 0.92 (positive) |
Analyst Ratings (HHUSF)
Wall Street analysts rate HHUSF "None", per Nexqual as of June 9, 2026 at 23:53 UTC.
| Consensus Rating | None |
|---|
Earnings (HHUSF)
| Next Earnings Date | 2026-08-13 |
|---|---|
| Revenue Estimate | $717.52M |
Source: Nexqual, June 9, 2026 at 23:53 UTC.
Financials & Fundamentals (HHUSF)
| Total Revenue | $2.52B |
|---|---|
| Revenue Growth (YoY) | +22.20% |
| Gross Margin | +12.65% |
| Operating Margin | -2.96% |
| Profit Margin | +2.86% |
| ROE | -0.84% |
| Debt / Equity | 48.68 |
| Current Ratio | 3.44 |
| Total Cash | $4.87B |
| Total Debt | $4.52B |
| Free Cash Flow | $-1.90B |
Source: Nexqual, June 9, 2026 at 23:53 UTC.
Financial Health Score (HHUSF)
Nexqual rates HHUSF's overall financial health "Mixed" across five dimensions, as of June 9, 2026 at 23:53 UTC.
| Growth | Strong — Revenue +21% YoY (annual) |
|---|---|
| Profitability | Critical — Gross margin 13%, operating -3% |
| Balance Sheet | Strong — $4.87B cash vs $4.52B debt, net cash position |
| Cash Flow | Weak — FCF negative: -$1.90B, burning cash |
| Efficiency | Critical — ROE -1%, ROA -0.5% |
Ownership (HHUSF)
| Insider Ownership | +40.35% |
|---|---|
| Institutional Ownership | +32.52% |
| Shares Outstanding | 1.33B |
| Float | 891.91M |
Source: Nexqual, June 9, 2026 at 23:53 UTC.
Leadership (HHUSF)
HHUSF is led by Bai Peng (age 62), President & Executive Chairman, per Nexqual as of June 9, 2026 at 23:53 UTC.
| President & Executive Chairman | Bai Peng (age 62) |
|---|---|
| Executive VP, CFO & Secretary of the Board | Yu-Cheng Wang (age 62) |
| Deputy Director of the Investor Relations | Kathy Chien |
| Senior Vice President | Bill Lin (age 57) |
Major Backers & Investors (HHUSF)
Notable institutional backers of HHUSF include Invesco, DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT., -HSBC ETFs Plc -HSBC Hang Seng TECH UCITS ETF, according to Nexqual as of June 9, 2026 at 23:53 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Invesco | 0.51% |
| DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT. | 0.27% |
| -HSBC ETFs Plc -HSBC Hang Seng TECH UCITS ETF | 0.2% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.62% |
| BlackRock | 0.91% |
Source: Nexqual, June 9, 2026 at 23:53 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ROHCY | Rohm Co. Ltd. | USD 32.26 | ▲ 1.77% |
| NRSDY | NORDIC SEMICONDUCTOR ASA | USD 19.43 | ▼ 5.63% |
| TSYHF | TravelSky Technology Ltd. | USD 1.26 | ▲ 6.78% |
| NDCVF | NORDIC SEMICONDUCTOR ASA | USD 19.65 | ▲ 0% |
| SHPMY | Shanghai Pharmaceuticals Holdin | USD 7.6 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:53 UTC. This page is informational and not investment advice.